The bill H. 4545 is a concurrent resolution introduced in the South Carolina General Assembly that allows for the consideration of additional matters after May 8, 2025, during the 2025 legislative session. Specifically, it permits the introduction, receipt, and consideration of H. 4262, which pertains to the restriction, regulation, or prohibition of mRNA gene therapies. This resolution outlines that these matters can be addressed prior to the sine die adjournment and includes provisions for concurrence, nonconcurrence, appointment of conferees, and the handling of conference reports and vetoes.

The resolution emphasizes that the General Assembly can engage with these additional matters alongside the regular legislative agenda, ensuring that the topic of mRNA gene therapies is given attention before the session concludes. This inclusion aims to facilitate a comprehensive discussion and decision-making process regarding the regulation of these therapies within the state.